Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | FZD3 |
| Upstream (Parents) |
|---|
| (<<) ALDOA → FZD3 |
| (<<) BMPR1A → FZD3 |
| (<<) CLCF1 → FZD3 |
| (<<) EP300 → FZD3 |
| (<<) EPHA1 → FZD3 |
| (<<) ETS2 → FZD3 |
| (<<) HCN2 → FZD3 |
| (<<) HMOX1 → FZD3 |
| (<<) ICAM2 → FZD3 |
| (<<) KCNK1 → FZD3 |
| (<<) KLF2 → FZD3 |
| (<<) MAP1B → FZD3 |
| (<<) NR3C1 → FZD3 |
| (<<) PLCG2 → FZD3 |
| (<<) PLK3 → FZD3 |
| (<<) PROCR → FZD3 |
| (<<) RRAS2 → FZD3 |
| (<<) SOCS3 → FZD3 |
| Downstream (Children) |
|---|
| FZD3 → AREG (>>) |
| FZD3 → F2RL1 (>>) |
| FZD3 → FHIT (>>) |
| FZD3 → FZD6 (>>) |
| FZD3 → NAV2 (>>) |
| FZD3 → NFATC4 (>>) |
| FZD3 → RAP1A (>>) |
